The stock price of Harrow Inc (NASDAQ: HROW) has jumped by 6.90 compared to previous close of 39.70. Despite this, the company has seen a fall of -18.07% in its stock price over the last five trading days. businesswire.com reported 2024-11-15 that NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences: Craig-Hallum 15th Annual Alpha Select Conference (Sheraton New York Times Square Hotel) November 19, 2024 1×1 Meetings Only BTIG 4th Annual Ophthalmology Day (Virtual) December 2, 2024 1×1 Virtual Meetings Only Piper Sandler 36th Annual Healthcare Conference (The Lotte New York Palace) Dec.
Is It Worth Investing in Harrow Inc (NASDAQ: HROW) Right Now?
The 36-month beta value for HROW is at 0.71. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for HROW is 30.47M, and currently, shorts hold a 8.48% of that float. The average trading volume for HROW on November 21, 2024 was 564.73K shares.
HROW’s Market Performance
HROW stock saw a decrease of -18.07% in the past week, with a monthly decline of -25.52% and a quarterly a decrease of 2.71%. The volatility ratio for the week is 10.72%, and the volatility levels for the last 30 days are 7.26% for Harrow Inc (HROW). The simple moving average for the past 20 days is -8.78% for HROW’s stock, with a 59.53% simple moving average for the past 200 days.
Analysts’ Opinion of HROW
Many brokerage firms have already submitted their reports for HROW stocks, with Craig Hallum repeating the rating for HROW by listing it as a “Buy.” The predicted price for HROW in the upcoming period, according to Craig Hallum is $24 based on the research report published on April 11, 2024 of the current year 2024.
B. Riley Securities, on the other hand, stated in their research note that they expect to see HROW reach a price target of $17. The rating they have provided for HROW stocks is “Buy” according to the report published on September 08th, 2022.
B. Riley Securities gave a rating of “Buy” to HROW, setting the target price at $16 in the report published on October 14th of the previous year.
HROW Trading at -11.37% from the 50-Day Moving Average
After a stumble in the market that brought HROW to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -28.35% of loss for the given period.
Volatility was left at 7.26%, however, over the last 30 days, the volatility rate increased by 10.72%, as shares sank -21.73% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +2.59% upper at present.
During the last 5 trading sessions, HROW fell by -18.07%, which changed the moving average for the period of 200-days by +326.53% in comparison to the 20-day moving average, which settled at $46.53. In addition, Harrow Inc saw 278.93% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at HROW starting from Opaleye Management Inc., who purchase 20,000 shares at the price of $9.97 back on Apr 25 ’24. After this action, Opaleye Management Inc. now owns 3,815,000 shares of Harrow Inc, valued at $199,400 using the latest closing price.
Opaleye Management Inc., the 10% Owner of Harrow Inc, purchase 11,715 shares at $10.29 during a trade that took place back on Apr 23 ’24, which means that Opaleye Management Inc. is holding 3,786,715 shares at $120,547 based on the most recent closing price.
Stock Fundamentals for HROW
Current profitability levels for the company are sitting at:
- -0.05 for the present operating margin
- 0.73 for the gross margin
The net margin for Harrow Inc stands at -0.2. The total capital return value is set at -0.03. Equity return is now at value -50.10, with -10.48 for asset returns.
Based on Harrow Inc (HROW), the company’s capital structure generated 0.76 points at debt to capital in total, while cash flow to debt ratio is standing at 0.02. The debt to equity ratio resting at 3.22. The interest coverage ratio of the stock is -0.4.
Currently, EBITDA for the company is 9.72 million with net debt to EBITDA at -49.94. When we switch over and look at the enterprise to sales, we see a ratio of 9.67. The receivables turnover for the company is 3.15for trailing twelve months and the total asset turnover is 0.48. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.54.
Conclusion
In conclusion, Harrow Inc (HROW) has had a mixed performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
